Cyclobenzaprine Hydrochloride
- Product NDC
- 0615-8182
- 11-digit product format
- 006158182
- Labeler code
- 0615
- Product ID
- 0615-8182_cb3fa04f-0ca1-4350-a29a-2ebe86233f64
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclobenzaprine Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA078048
- Marketing category
- ANDA
- Marketing start
- 2014-07-31
- Marketing end
- 0000-00-00
- Substance
- CYCLOBENZAPRINE HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0615-8182-05 | 00615818205 | 15 TABLET, FILM COATED in 1 BLISTER PACK (0615-8182-05) | 2020-02-13 | 0000-00-00 | No | No | Current |
| 0615-8182-39 | 00615818239 | 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8182-39) | 2019-01-10 | 0000-00-00 | No | No | Current |